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Abstract: Periodontal disease can be treated in several ways. This paper reviewed whether
antimicrobial photodynamic therapy (aPDT) in addition to scaling and root planing (SRP) produces
improved clinical results over systemic antibiotics (ABs) in conjunction with SRP in adults
with periodontitis. Studies were searched using the following electronic databases: MEDLINE,
the Cochrane Database of Systematic Reviews, and the Web of Science Core Collection up to and
including November 2018. Four randomized controlled trials (RCTs) were reviewed to maximise the
reliability of the evidence. All participants suffered from either chronic or aggressive periodontitis
and each study contained SRP as an adjunct to ABs or aPDT. To determine whether groups showed
improvement after treatment, the outcome parameters chosen were probing depth (PD), clinical
attachment level (CAL), and bleeding on probing (BOP). Despite finding significant improvements
in all groups, the differences among groups were not consistently statistically significant. The lack
of homogeneity in the results among these studies indicates that it was not possible to determine
a conclusion about whether aPDT or AB as an adjunct to SRP provides better improvements in
periodontitis as measured by PD, CAL, and BOP. Further studies with more similar study designs are
required before firm conclusions can be deduced.
Keywords: periodontitis; scaling; photodynamic; therapy; antibiotics; outcome
1. Introduction
Periodontal disease is the inflammatory process that occurs in response to chronic infection or a
build-up of dental plaque around the tooth tissue. Anaerobic bacteria including primarilyPorphyromonas
gingivalis, Tannerella forsythus, and Treponema denticola cause periodontal tissue destruction, alveolar
bone loss, and eventually the loss of the tooth [1]. Currently, the most widespread treatment for
periodontitis involves the physical removal of plaque through debridement and/or using antimicrobial
agents [2]. Initially, scaling and root planing (SRP) is carried out with the use of hand or ultrasonic
instruments to debride the root surface, allowing the formation of a long junctional epithelium [3].
Clinically, it is difficult to determine the effectiveness of the debridement, especially where there
has been extensive tissue loss and the periodontal pockets are deep and where root furcations are
difficult to access [4]. Thus, small amounts of bacteria are likely to be left residing in the pocket with
the significant effect of continual breakdown of tissue [5].
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Without surgical debridement, the use of local or systemic antibiotics (ABs) can assist towards the
treatment outcome. However, their use is limited to specific patients (such as those diagnosed with
aggressive periodontitis) and is commonly used in practice for those who have previously had two
courses of SRP with no improvement in periodontal pocket depth [6]. Furthermore, the undesirable
side effects and increase in AB resistance over time have reduced the number of cases treated in this
way [7].
For these reasons, it is expected that the discovery of an alternative method would be ideal
to remove the periodontal bacteria from the pocket without any unwanted negative side effects.
Antimicrobial photodynamic therapy (aPDT) has the potential to become a conventional therapy used
in conjunction with SRP. The photosynthesiser used in aPDT is photoactivatable and binds to specific
cells and is activated by a light source (a low intensity laser with a suitable wavelength) in the presence
of oxygen. This produces free radicals or reactive oxygen species, primarily singlet oxygen, and causes
localised photodamage cell death [8]. The aPDT has the advantage of targeting and immediately
suppressing specific bacterial cells. In addition, it has a minimal risk of AB resistance and side effects,
and as this is the main issue with the AB, it makes this a much safer long-term treatment option if
found to have a significant effect on the periodontal disease [9]. A systematic review undertaken in
2016 [10] failed to draw any strong conclusions and the efficacy of both treatment types is unclear. Thus,
it is important to compare their effectiveness to facilitate the current understanding of periodontal
treatment by either AB or aPDT. As a result, the aim of this review is to determine whether the treatment
of periodontitis using aPDT alongside SRP would produce an improvement in the clinical outcome
compared to antibiotics as adjunct to SRP.
Inclusion Criteria
The PICO (Participants/Interventions/Comparisons/Outcomes) framework (Table 1) was used to
direct the literary research to address our evidence summary question: “Is antimicrobial photodynamic
therapy used in addition to localised non-surgical periodontal therapy more effective in improving
periodontal health than systemic antibiotics (ABs) used in addition to non-surgical periodontal
therapy?”.
Table 1. The PICO (Participants/Interventions/Comparisons/Outcomes) framework.
Patient/Population/Problem Adult (>18) Patients with Periodontitis
Intervention Photodynamic Therapy (aPDT)
Comparison Systemic Antibiotics (ABs)
Outcome Periodontal Pocket Depth (PD) Reduction
2. Methods
2.1. Search Strategy
Searches were undertaken to identify the appropriate studies for inclusion in this review. Three
databases used were: MEDLINE (via. OVID SP) (1946–2018), the Cochrane Database of Systematic
Reviews (CDSR) (1996–2018), and the Web of Science Core Collection (1900–2018) (see Appendix A for
details on the search). Only studies written in English were considered for inclusion.
2.2. Additional Searches
In addition to searching the databases above, handsearching into “Google Scholar” and the
“Google Search Engine” was conducted using different combinations of the MeSH (Medical Subject
Headings) and keyword searches used in the three databases. However, only papers that had previously
been found in the search using the other three databases were found.
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2.3. Search Criteria
The selection criteria were decided upon through thorough discussion and research.
2.4. Types of Study
Randomised control trials (RCTs) were included. They are the strongest in the hierarchy of
evidence as causal inferences can be made, and concealment allocation and randomization avoid
allocation bias and unbiased distribution of confounders. It was decided to keep controlled/comparative
clinical trials within this review, as their double-blind methodology helps eliminate any bias. In vitro
studies were to be excluded due to the potential for results not being reproduced within the clinical
environment. Case series studies were omitted due to the lack of a control group.
2.5. Types of Participants
All patients, of either gender, had to be diagnosed with aggressive or chronic periodontitis and
aged 18 or over. Chronic periodontitis cases usually have an abundance of plaque and calculus which
match with the amount of periodontal destruction. Aggressive periodontitis is characterised by a
rapid rate of disease progression, absence of any systemic involvement, and familial aggregation of
cases [11].
2.6. Types of Intervention
All patients had to have received SRP with the control group treated with AB and a test group
treated with aPDT. Therefore, studies without SRP were excluded. Only diode lasers had to have been
used in the aPDT.
2.7. Types of Outcome Measure
Primary and secondary outcomes measuring probing depth (PD) and clinical attachment
levels (CAL) were included. Probing depth and CAL are two of the most important indicators
of periodontal health.
Primary outcome measures:
• Probing depth changes.
Secondary outcome measures:
• Clinical attachment level changes;
• Bleeding on probing changes.
2.8. Search Outcome and Screening
The MEDLINE, Web of Science, and Cochrane database searches completed the initial identification
phase as seen in the PRISMA flow diagram (Figure 1). The first step was to remove the duplicated
results from the database results. The screening phase was divided and conducted by two authors (S.P.)
and (A.P.). The screening method involved reading the Title and Abstract of each paper and including
them in the next phase (eligibility) if they appeared to address the designed PICO framework. For
any results for which acceptability was uncertain, the second screener was consulted. If the Title or
Abstract were vague, the full article was read at that point to minimise risks of excluding an eligible and
appraisable paper. In the eligibility phase, both authors engaged in full readings of every paper, and
using the chosen inclusion and exclusion criteria, decided which of the papers should be qualitatively
analysed. Any papers that both authors deemed suitable for inclusion were automatically agreed on.
For any papers where only one author believed it should be included or excluded, a decision was
made upon re-reading and further discussion.
Dent. J. 2019, 7, 108 4 of 14
Dent. J. 2019, 7, x FOR PEER REVIEW 4 of 14 
 
 
Figure 1. PRISMA flow diagram. 
3. Results 
3.1. Search Outcome and Screening 
The MEDLINE, Web of Science, and Cochrane database searches resulted in 116, 130, and 1 
articles, respectively, which completed the initial identification phase of the PRISMA flow diagram. 
The deletion of duplicate papers resulted in 202 results. The initial screening phase reduced the 
number of studies to 10 that required full-text reading. The eligibility phase resulted in 5 papers 
reporting on 4 studies for qualitative analysis which are summarised in Table 2. The 5 full-text papers 
that were excluded from this review are summarised in Table A4.  
 
Figure 1. PRISMA flow diagram.
3. Results
3.1. Search Outcome and Screening
The MEDLINE, Web of Science, and Cochrane database searches resulted in 116, 130, and 1 articles,
respectively, which completed the initial identification phase of the PRISMA flow diagram. The
deletion of duplicate papers resulted in 202 results. The initial screening phase reduced the number of
studies to 10 that required full-text reading. The eligibility phase resulted in 5 papers reporting on
4 studies for qualitative analysis which are summarised in Table 2. The 5 full-text papers that were
excluded from this review are summarised in Table A4.
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Table 2. A summary of the five papers reporting on four studies included in the review.
1st Author, Year, and
Country
Total (n), Intervention (I),
Control (c)
Patient Population, Baseline
Clinical Characteristics,
Demographic (Mean (SD)) or
n Unless Otherwise Stated
Intervention Comparator Results
Andere et al. (2018) [12]
N = 36
I1 = 9
I2 = 9
I3 = 9
C = 9
Overall Age
<35 years old
Overall Gender
2 males
34 females
Number of teeth
All patients had at least 20 teeth
I1: SRP and placebo pills
2×/day for 3 days + one
application of aPDT (aPDT)
I2: SRP and clarithromycin
(500 mg) 2×/day for 3 days
(AB)
I3: SRP and clarithromycin
(500 mg) 2×/day for 3 days
and one application of aPDT
(AB + aPDT)
SRP: scaling and placebo
pills 2×/day for 3 days
Statistically significant results were found in PD,
clinical attachment level, and BOP among all
intervention groups compared to the baseline.
Probing Depth (PD)
At 6 months, all intervention groups exhibited
reduced PD compared to the C group.
Clinical Attachment Level (CAL)
Groups AB and AB + aPDT showed a significant
gain in comparison to groups SRP and aPDT
(difference in clinical attachment level between
baseline and 6 months: SRP = 2.3 ± 0.8 mm; aPDT =
2.4 ± 1.1 mm; AB = 3.0 ± 1.8 mm; AB + aPDT = 3.0
± 1.0 mm).
Bleeding on probing (BOP)
BOP decreased in all groups compared to the
control group.
Groups AB and AB + aPDT displayed the largest
decrease (difference in BOP between baseline and 6
months: SRP = 38.8%; SRP + aPDT = 33.3%; SRP +
AB = 16.6%; SRP + AB + aPDT = 16.6%
Arweiler, et al. (2013,
2014) [13,14]
36 participants started, (1
loss to FU in the aPDT
group).
aPDT = 17
AB = 18
Age
aPDT gp = 37.4 ± 8.0
AB gp = 34.7 ± 9.1
Overall Gender
12 males
23 females
I1: SRP and AB (375 mg of
amoxicillin and 250 mg of
metronidazole 3× daily) for
7 days.
I2: UPD and AB (400 mg of
metronidazole and 500 mg of
amoxicillin three times a day)
for 7 days (AB)
C1: UPD and 2 courses of
aPDT
C2: SRP and 3 periods of
aPDT (two applications
on the day of SRP and 1×
after 7 days)
The results from baseline to 3 months indicated a
statistically significant improvement within the
parameters measured among both the AB and the
aPDT groups.
PD
AB group produced better results overall (5.0 ± 0.8
mm to 3.2 ± 0.4 mm). aPDT had a smaller decrease
(5.1 ± 0.5 mm to 4.0 ± 0.8 mm)
CAL
AB group showed greater improvements than the
aPDT group (from 5.5 ± 1.1 mm to 3.9 ± 1.0 mm in
comparison to 5.7 ± 0.8 mm to 4.7 ± 1.1 mm).
BOP
AB group improved from 85.7% ± 15.9% to 34.6% ±
22.8%, while a smaller improvement was seen in the
aPDT group from 70.4% ± 22.4% to 37.7% ± 21.3%.
After 6 months, the AB group produced an
improvement in the measures including PD, CAL,
and BOP. Between-group comparisons were
non-significant.
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Table 2. Cont.
1st Author, Year, and
Country
Total (n), Intervention (I),
Control (c)
Patient Population, Baseline
Clinical Characteristics,
Demographic (Mean (SD)) or
n Unless Otherwise Stated
Intervention Comparator Results
Tabenski et al. (2017) [15]
I: 15
C1: 15
C2: 15
Median Age
aPDT + SRP gp = 54
Minocycline + SRP gp = 56
SRP alone gp = 57
Overall Gender
21 males
24 females
I: aPDT and SRP (aPDT)
C1 (positive control):
Minocycline and SRP (AB)
C2: (negative control) SRP
alone
Significant improvements in clinical and
microbiological parameters were found for all
groups after 6 weeks and 3, 6, and 12 months. The
greatest improvement came from the AB group.
Between-group comparisons were non-significant.
Comparing baseline to 12 months, statistically
significant reductions were seen in the PD (aPDT =
2 mm; AB = 3 mm; SRD = 2 mm).
Theodoro, et al. (2017)
[16]
I: 17 with 3 participants
loss to FU (AB).
C: 17 with 4 loss to FU
(aPDT)
Total analysed = 27
Age
Between 32 and 66 years old
Gender
15 males
12 females
SRP and AB (400 mg of
metronidazole and 500 mg of
amoxicillin 3 times a day) for
7 days
SRP and 3 immediate
episodes of aPDT
After 90 days, statistically significant improvements
were seen in all the measured clinical parameters,
with the AB group having the superior
improvement.
PD
AB group showed a greater decrease from 3.99 ±
0.57 mm at baseline to 3.69 ± 0.38 mm after 90 days
compared to 3.78 ± 0.42 mm down to 3.54 ± 0.41
mm in aPDT.
CAL
A larger improvement in the AB group (from 4.91 ±
1.20 to 4.62 ± 1.07) when compared to the aPDT
group (from 4.43 ± 0.72 to 4.25 ± 0.71).
BOP
Both groups showed a decrease, but the aPDT group
displayed a greater reduction (from 78.36% ± 11.22%
to 59.50% ± 13.01%) compared to the AB group
(from 75.04% ± 19.09% to 60.58% ± 15.95%).
SRP = Scaling and Root Planing, aPDT = Antimicrobial Photodynamic Therapy, CAL = Clinical attachment level, PD = pocket depth, BOP = bleeding on probing, FU = follow-up,
Gp = group.
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The risk of bias assessment for these four studies is shown in Table 3.
Table 3. Risk of bias for the four studies.
Andere (2018)
[12]
Theodoro (2017)
[16]
Arweiler (2013
and 2014) [13,14]
Tabenski (2017)
[15]
Random sequence
generation Low risk Low risk Low risk Low risk
Allocation concealment Low risk Low risk Unclear Unclear
Blinding of participants and
personnel Low risk Low risk Unclear High risk
Blinding of outcome
assessors Low risk Low risk Low risk Low risk
Incomplete data outcome Low risk High risk Low risk Unclear
Selective outcome reporting High risk Unclear Unclear High risk
Other bias Low risk Low risk Low risk Low risk
All four studies were assessed as having a low risk of bias for random sequence generation and
blinding of outcome assessors [12–16]. Two studies were assessed as having a low risk of bias for
allocation concealment [12,16], whilst this was unclear in two studies [13–15]. Blinding of participants
and personnel was assessed as having a low risk of bias in two studies [12,16], high risk in one
study [15] and was unclear in the fourth [13,14]. Incomplete data outcome was assessed as having
low risk of bias in two studies [12–14], high risk in one study [16] and was unclear in the fourth [14].
Selective outcome reporting was assessed as having high risk of bias in two studies [12,15] and was
unclear in two studies [13,14,16]. All four studies were assessed as having a low risk of bias for any
other bias. The most recent 2018 study [12] scored a low risk on the most risk of bias criteria implying
that this study had the least bias overall.
The four included studies in this review resulted in five papers published between 2013 and
2018 [12–16]. The four studies were undertaken in Brazil, Switzerland, Poland and Germany. The
reviews included participants suffering from aggressive periodontitis (n = 3) and chronic periodontitis
(n = 2).
A meta-analysis of the results was not conducted due to the limited number of RCTs available,
the variation in interventions implemented, and the heterogeneity of outcomes reported.
3.2. Pocket Depth
Andere et al. (2018) [12] indicated that all therapies had a statistically significant decrease in
pocket depth at three months after treatment versus baseline. However, over 3 months there was
no significant difference between the SRP + aPDT and SRP group pocket depths. Over 6 months,
group 3 (UPD + Clarithromycin) and 4 (UPD + Clarithromycin + aPDT) had a statistically significant
higher decrease in probing depths compared to groups 1 (SRP) and 2 (SRP + aPDT) (p < 0.05). This
decrease in pocket depth supports an earlier study by Theodoro et al. [16]. However, in contrast to
Andere et al. [12], this study [16] did not find a difference in the pocket depth reduction between aPDT
and antibiotics.
An earlier study by Arweiler et al. [13] in 2013 contradicts Theodoro et al. [16] regarding pocket
depth results. However, it mirrors Andere et al. [12] by concluding both AB and aPDT led to significant
decreases in pocket depth, and that AB had a significantly higher reduction in pocket depth than aPDT
3 months after treatment. Arweiler et al. [13] then recorded results 6 months after treatment, and this
then formed a second paper [14]. These findings were in line with the three-month results, indicating
that both AB and aPDT significantly decreased pocket depth, and that AB had a significantly higher
reduction in pocket depth than AB.
Tabenski et al. [15] support Theodoro’s [17] findings of a reduction in pocket depth in both the
aPDT and AB groups, however, 12 months after baseline. While the AB group had greater pocket
depth reduction than the aPDT group, no differences were found (p > 0.05).
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3.3. Clinical Attachment Loss
Andere et al. (2018) [12] observed a significant decrease in CAL in all therapy groups, although
the differences in CAL between the SRP + AB and SRP + aPDT groups were not significant. Only the
SRP + AB + aPDT group’s CAL reduction was significantly more than the other therapies. However,
as this review is comparing SRP + AB and SRP + aPDT, this result was not valid. The results for CAL
contradict the results of Theodoro et al. [16] which found that, while all therapies caused significant
decreases in CAL, the SRP + aPDT decreased CAL significantly more than the SRP + AB group for
intermediate pockets (≤7 mm at baseline) although not for deep pockets (>7 mm) [16].
Andere et al. [12] also support the studies by Arweiler et al. [13,14], where both the SRP + AB and
SRP + aPDT groups had a significant decrease in CAL, and the SRP + AB group had a significantly
greater reduction in CAL comparatively. Finally, Tabenski et al. [15] support the findings that the SRP +
aPDT and SRP + AB groups both significantly reduced CAL. Whereas, in contradiction to the previous
three studies [13,14,16], it did not demonstrate a between-group difference [15].
3.4. Bleeding on Probing
At 6 months, Andere et al. [12] demonstrated a statistically significant BOP reduction compared
to baseline values. While Group 3 and 4 (the AB groups) showed less BOP compared to Groups 1 and
2, the differences were not statistically significant. This was mirrored by Theodoro et al. [16], who
similarly concluded the SRP + AB and SRP + aPDT treatment groups had significantly lower BOP,
although the differences among them were not significant. This is also reflected in the remaining three
studies. Although significant decreases in BOP in both the SRP + AB and SRP + aPDT groups were
found, the differences among them were not significant [13–15].
4. Discussion
4.1. Summary of Findings
The aim of this systematic review was to assess if aPDT + SRP was more effective in improving
periodontal health (measured using PD, CAL, and BOP) than AB + SRP. A similar review was previously
published in 2016 [10]. However, to our knowledge at the time of writing, this review is the first to
include more recent studies published in 2017 [16] and 2018 [12].
In all four studies, both treatments (SRP + aPDT/UPD + AB) had a statistically significant decrease
in all outcomes, reflected in two further studies [17,18].
For PD reduction, two out of the four studies concluded UPD + AB as significantly more effective
than SRP + aPDT [12–14]. The other two studies concluded no difference in effectiveness [15,16],
supporting an earlier study [19]. However, their inclusion of diabetic patients limits the scope of valid
comparison. There was little consensus as to the effect of the two modalities on CAL. One study found
aPDT + SRP to be significantly better in intermediate pockets and no difference among the treatment
groups for deep pockets [16].
None of the studies concluded that one treatment modality was significantly better for all three
outcomes. No two studies had the same result for all three outcomes, signifying a fundamental
contradiction throughout the results. This means that our review cannot definitively conclude that
either adjunct (aPDT/AB) is more effective than the other. The only consistent result was that none of
the studies showed any significant differences among the treatment groups for BOP reduction. While
this suggests that SRP + AB/UPD + aPDT are equally effective, this is only one periodontal health
outcome measure. Without statistically significant PD and CAL reduction, such a conclusion is weak.
4.2. Strengths and Limitations
Inclusion criteria within chosen studies may have introduced bias making their results less
generalisable or valid. For example, one study included both non-smoking and smoking patients [15].
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Although we excluded studies that only used smoking patients, in the future we recommend excluding
studies with any smoking patients.
Only two of the four studies gave oral hygiene instruction (OHI) to the sample before the treatment
began, and none of the studies recorded the patient’s oral hygiene prior to treatment. Proficient OHI
is necessary for any periodontal treatment to be successful by influencing calculus/plaque removal,
and without it, periodontal treatment success is compromised. Lack of control over this factor in two
out of the four studies questions the reliability/validity of their results. Patient demographics may
have limited the studies’ generalisability as well. For example, one study used 35-year-olds or less
from Sao Jose, Brazil [12], whereas another used 30 to 70-year-olds from Araçatuba (Brazil) [16]. The
bio-physiological/cultural/behavioural differences among countries limit both studies’ generalisability
to populations in other countries. The results of one study may be generalisable to a greater population
as a wider age range was used [16] whilst another may only be valid for patients under 35 years
old [12].
One study did not mention the examiner calibration; therefore, we have no quantitative measure
of the precision/reliability/reproducibility of their outcome measurements [13,14]. Not accounting
for the subjectivity of periodontal assessments, this may have introduced assessor bias and reduced
assessment reliability. This limits the reproducibility of the conclusions drawn within this study.
Three studies [12–14,16] had more subjects than the minimum determined by power calculations,
giving narrow confidence intervals, higher statistical power, and a possible reduction in chance results.
One study used a 1.5 mm standard deviation, 0.05 significance level, and a statistical power of 0.8 to
determine 17 as the minimum subject number to detect significance [15]. However, this study did not
manage to recruit enough participants and so was underpowered. Loss to follow-up bias is important
as those who fail to complete the study are more likely to have a different prognosis [20]. One study lost
seven out of thirty-four subjects to follow-up [16]. As there was no intention-to-treat analysis [21], the
loss to follow-up may have affected the power calculation to increase the likelihood of chance results.
Variation in the aPDT parameters among the studies was a key limitation. All studies had
discrepancy in power density, photosynthesiser concentration, and fibre diameter, which can affect
power/energy release and, therefore, efficacy [10].
The aPDT application numbers varied between one and four in the studies which could have
influenced its efficacy/outcome measure improvements. For example, although one study found
that SRP + AB improved PD significantly more than SRP + aPDT, only one aPDT application was
used [12]. However, another study used three applications and found no significant difference among
treatment groups [16], whilst another study found that three applications of aPDT enhanced clinical
and microbiological outcomes [22], supporting an earlier study which found improved results with
five aPDT applications [23]. This shows that increasing the number of aPDT applications improves its
efficacy. Moreover, there was insufficient evidence on the optimum application number. Therefore,
comparison validity among aPDT/AB was compromised as the results were affected by the bias of
aPDT not being optimally given as opposed to being clinically less effective.
The inconsistency in antibiotic drugs/doses among the studies introduced bias. For example,
one study concluded no significant differences between aPDT + SRP and AB + SRP effectiveness [15];
however, another found AB + UPD to be more effective [16]. This latter study’s results may be due
to the use of amoxicillin + metronidazole rather than minocycline. Therefore, the differences in the
results among the studies can be attributed to antibiotic type rather than the antibiotic efficacy as a
better/worse therapy.
The selected studies had participants with either chronic periodontitis or aggressive periodontitis.
Their differing pathophysiologies and, therefore, periodontal treatment (AB/aPDT) response [24] makes
the result comparisons among patient types less valid. For example, one study’s conclusion that there
was no significant difference among treatment groups for PD was confined to chronic periodontitis
patients; however, another study [12] concluded SRP + AB was significantly more effective.
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Another fundamental limitation in our review was that the inclusion criteria did not specify which
aPDT, AB or periodontitis type/parameters were to be included. However, further RCTs with the same
aPDT/AB/periodontitis parameters are recommended to increase the reliability/validity of the results,
from which clearer conclusions can be made.
4.3. Clinical Implications
Despite the new published studies, this review reflects the conclusion of Akram et al.’s 2016
review [10] that it is not possible to determine which SRP adjunct, aPDT or AB, is more clinically
effective in improving periodontal health. None of the studies in this current review concluded that
either SRP + AB or SRP + aPDT was more effective than the other in reducing PD, CAL, and BOP.
The results were highly contradictory. It was not possible to conclude that either treatment group
had significantly better results for any outcome across all studies. Comparisons among the studies
were limited by study design factors which may have affected their reliability, validity, reproducibility,
and generalisability.
4.4. Suggestions for Future Research
There are published systematic reviews based on extensive studies that focus on the effectiveness
of aPDT + SRP/SRP + AB individually. However, there is a lack of research directly comparing their
effectiveness. Moreover, there is a need for further RCTs with the same aPDT/AB/periodontitis types
in order to increase the comparison reliability/validity. Quantitative analysis should be included in
future reviews.
5. Conclusions
No clear conclusion of the superior effectiveness of aPDT + SRP/SRP + AB for any outcome
measure can be reached, and this strongly reflects an earlier systematic review [10]. This review
highlights the need for further studies comparing aPDT + SRP/AB + SRP effectiveness using controlled
parameters. This will hopefully give periodontists and dental clinicians a definitive answer as to which
treatment modality, combined with non-surgical periodontal therapy, is most effective at improving
periodontal health.
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Appendix A
Details of the search strategy:
Appendix A.1. MEDLINE (Via OVID SP)
Table A1 in the Appendix A summarises the search strategy used in MEDLINE to identify possible
studies that could be used for this review. The four overarching concepts within our PICO framework
requiring dynamic and focused search terms were photodynamic therapy, scaling and root planing,
antibiotics, and periodontitis. The specific MeSH terms used by MEDLINE relating to these concepts
were discovered (third column of Table A1). There was an underestimation in the variability in the
terminology required. For example, clinicians commonly refer to periodontal scaling treatment as
supragingival/subgingival scaling/debridement. However, in MEDLINE, the MeSH related to this
treatment is: “Root Planing”, “dental scaling”, and “periodontal debridement”. Recognising this was
fundamental to widening the scope of the search. However, it was important to use “scaling”, “root
planing”, and “debridement” in the keyword search as the equivalent MeSH terms mentioned are
not necessarily how the procedures are described clinically or in papers. Not doing so may have
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limited search results. Similarly, preparatory reading into the subject area highlighted this diode-laser
treatment commonly referred to as “photodynamic therapy”. However, on MEDLINE it was important
to recognise the MeSH for this as “photochemotherapy” which included “photodynamic therapy”
alongside other descriptors. Moreover, due to the uncertainty in this terminology, we conducted the
wildcard searches, photochemotherap* or photodynamic* to consider any other lexical variations;
“Photo adj2 therap” was used to cover any alternative variations. Finally, a cumulative search was
undertaken which included the MeSH and keyword phrases (for example, row 4 of Table A1) using
the Boolean “OR” operator. This resulted in a total cumulative search of all the MeSH and keywords
for the four concepts using the Boolean “AND” operator.
Table A1. Search strategy used for MEDLINE (Via OVID SP).
Number Search (MESH) Words/Phrasesin This Search
Keywords in This
Search Results
1
periodontitis/or aggressive
periodontitis/or chronic
periodontitis/or periodontal
pocket/
periodontitis, aggressive
periodontitis, chronic
periodontitis, periodontal
pocket
23,828
2 (periodontitis orperiodontal).mp.
periodontitis,
periodontal 83,739
3 1 or 2 83,739
4
dental scaling/or root
planing/or periodontal
debridement/
dental scaling, root
planing, periodontal
debridement
4188
5 (“scaling” or “root planing” or“debridement”).mp.
scaling, root
planing,
debridement
74,702
6 Anti-Bacterial Agents/ anti-bacterial agents 307,881
7
(“antibacterial agents” or
antimicrobial* or
antibiotic*).mp.
antibacterial agents,
antimicrobial,
antibiotic
578,051
8 6 or 7 578,051
9 Photochemotherapy/ photochemotherapy 17,227
10
(Photochemotherap* or
photodynamic* or (photo adj2
therap)).mp.
photochemotherap*,
photodynamic*,
(photo adj2 therap)
26,754
11 9 or 10 26,754
12 4 or 5 74,702
13 3 and 8 and 11 and 12 116
Appendix A.2. Web of Science Core Collection
This database differs to MEDLINE as it is keyword searching only as opposed to subject heading
and keyword searching. This made the searching strategy less complex, thus an open-ended search
strategy collated as many results as possible. The four concepts within the PICO framework discussed
above were covered through the keyword searches, detailed in Table A2. For example, searching
“periodontitis or periodontal” covered “aggressive periodontitis, chronic periodontitis, periodontal
disease and periodontal pocketing”, which was searched in the MEDLINE due the use of MeSH and
keyword searches. Boolean “OR” operators were used to collate searches for each of the four concepts
and then the “AND” completed the final combined search as seen in Table A2 row 6.
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Table A2. Search strategy used for the Web of Science Core Collection.
Number Search (MESH) Words/Phrasesin This Search Keywords in This Search Results
1 TOPIC: (periodontitis ORperiodontal) Periodontitis, periodontal 59,477
2 TS = (“scaling” OR “rootplaning” OR “debridement”)
Scaling, root planing,
debridement 229,915
3
TOPIC: (“antibacterial agents”
OR antimicrobial* OR
antibiotic*)
antibacterial agents,
antimicrobial*, antibiotic* 465,002
4 TOPIC: (photochemotherapy*OR photodynamic*)
photochemotherapy*,
photodynamic* 44,680
5 1 AND 2 AND 3 AND 4 130
Appendix A.3. Cochrane Database of Systematic Reviews (CDSR)
The Dentistry and Oral Health section has 197 (Cochrane) reviews. Therefore, the focused search
strategies as required in the previous two databases were not enforced. The search strategy in this
database was to enter “photo*” into the “Title Abstract Word” search tool which had a filter for
“Dentistry and Oral Health”-related reviews (Table A3). This resulted in 31 Cochrane Review titles
(Figure A1). A manual sift through the Title and Abstracts of these titles only found one Cochrane
Review that was related to the PICO framework (Figure A2).
Table A3. Search strategy used for the Cochrane Database.
Number Search (MESH) Words/Phrasesin This Search
Keywords in This
Search Results
1
“photo*” searched in Title
Abstract Keyword’ filtered for
Dentistry and Oral Health
photodynamic 31
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Table A4. The five full-text studies excluded in this review.
Study and Date Reference Reason for Exclusion
Grzech-Les´niak et al. (2018) [24] Used aPDT and AB on same participants
Macedo et al. (2013) [25] Participants were diabetic
Ramos et al. (2016) [18] Participants were diabetic
Skurska et al. (2015) [26] Dissimilar outcome measures
Theodoro et al. (2018) [17] Participants were smokers
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